Global implant company DIO (039840) announced on the 3rd that it has signed a strategic memorandum of understanding (MOU) with Ray, a medical imaging equipment specialist, to expand in global markets.
Through this agreement, DIO aims to maximize synergies in the global market by integrating Ray's diagnostic equipment with its digital implant system.
DIO will leverage its global network to sell Ray's dental digital diagnostic equipment, while Ray will provide technical information and training support for the equipment. The two companies also plan to share market intelligence in key strategic regions and jointly develop region-specific sales strategies.
CT-based three-dimensional diagnosis has become an essential tool in implant treatment. This is because accurate assessment of alveolar bone height and width, bone density, nerve location, and maxillary sinus structure is difficult with two-dimensional imaging alone. In particular, implant placement position and angle are critical factors that determine treatment outcomes, highlighting the growing importance of precise diagnosis during the pre-planning stage.
"Digital equipment is an essential component of DIO's artificial intelligence (AI) platform business," said Kim Jong-won, CEO of DIO. "Ray's digital equipment technology has already been proven in the market, making them an important partner in DIO's AI roadmap."
The 'DIO AX PLATFORM,' an AI platform currently being developed by DIO, is a next-generation platform that uses AI to rapidly and precisely perform the entire implant process—from patient diagnosis to guided surgery design, fixture placement, prosthetic design, and post-treatment management.